Publications

Preclinical pharmacokinetics, antitumor activity and single ascending dose tolerability of GBO-006 nanosuspension, a selective polo-like kinase 2 (PLK2) inhibitor

Maddi S, Lenkalepally S, Srivastava P, Jeyaraj DA, Chowdhury AR, Rajagopalan L, Gupta JB

Drug Invention Today 10: 1-9